Back to search

Boston University

Broadening the scope of chimeric antigen receptor therapies

Abstract

dc:description.abstract

The field of Chimeric Antigen Receptor (CAR) based therapies has led to a paradigm shift in medicine: cells as drugs. The use of cell-based therapies to treat cancer has revolutionized the field of cancer immunotherapy and made the hope of a cancer cure a reality for many patients. While the landscape of CAR-based therapies is predicted to transform the field of cancer therapy, there are several shortcomings that still need to be addressed. First, while some patients experience long-lasting remission, many others relapse after treatment. Second, the use of CAR-based therapies has been primarily limited to hematological malignancies and have yet to be successfully developed for use against solid tumors. Finally, due to the high price tag and lengthy manufacturing process, CAR-based therapies remain inaccessible to many patients who could benefit from them. This thesis will examine these challenges and review the various strategies that are currently used to address them.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rosenberg, Erin
Advisors dc:contributor.advisor
  • Franzblau, Carl
  • Romney, Carla

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/45647

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Rosenberg, Erin. Broadening the scope of chimeric antigen receptor therapies. masters thesis, Boston University, 2022. https://hdl.handle.net/2144/45647